Concepedia

Dominic Tilden

DT

14

Publications

463

Citations

12

H-Index

2001

Active since

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

The University of Sydney

Dominic Tilden is an author at Eli Lilly (United States) specializing in medicine, outcomes research, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2001–2020

14

Publications

14

Cost-Analysis Comparison of Outpatient See-and-Treat Hysteroscopy Service with Other Hysteroscopy Service Models

Ertan Sarıdoğan, Dominic Tilden, David Sykes et al. · Journal of Minimally Invasive Gynecology · 2010 · 79 citations

, , +9

Health State Utilities for Childhood Attention-Deficit/Hyperactivity Disorder Based on Parent Preferences in the United Kingdom

Kristina Secnik, Louis S. Matza, Suzi Cottrell et al. · Medical Decision Making · 2005 · 55 citations

Cost-effectiveness of mechanical thrombectomy for acute ischemic stroke: an Australian payer perspective

Nimita Arora, Koji Makino, Dominic Tilden et al. · Journal of Medical Economics · 2018 · 52 citations · Full text

Cost–utility analysis of recombinant factor VIIa (NovoSeven<sup>®</sup>) in six children with long‐standing inhibitors to factor VIII or IX

H. Ekert, T.B. Brewin, W. Boey et al. · Haemophilia · 2001 · 50 citations

, , +15

Retrospective cost analysis of gemcitabine in combination with cisplatin in non-small cell lung cancer compared to other combination therapies in Europe

Joan H. Schiller, Dominic Tilden, M Aristides et al. · Lung Cancer · 2003 · 45 citations

, , +6

Rows per page

1–5 of 14